$3.090
-0.030 (-0.96%)收盘时
- High
- 3.200
- Open
- 3.160
- VWAP
- 3.08
- Vol
- 56.09K
- Mkt Cap
- —
- Low
- 2.950
- Amount
- 172.77K
- EV/EBITDA, TTM
- -2.48
QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.
AI analysis of QT Imaging Holdings Inc (QTI)
buyQT Imaging Holdings Inc appears to be a good buy right now due to its recent 103% revenue growth in Q2 2026, bringing total revenue to $7.4 million, and a current price of $3.09, which is below its historical SMA of $4.982. The company also received FDA approval for enhanced product capabilities, which could drive future sales. However, the main risk is the high debt-to-equity ratio of 680.85%, indicating potential financial instability.
估值指标
事件时间线
资讯
9.508-13Yahoo FinanceQT Imaging Holdings Reports 103% Revenue Growth in Q2 2026
2.008-13NASDAQ.COMQT Imaging (QTI) Q2 2026 Earnings Call Transcript
5.007-29NewsfilterQT Imaging Appoints New Chief Science Officer
8.507-28NewsfilterQT Imaging Receives Regulatory Approval for Commercialization in Israel
7.007-07NewsfilterQT Imaging Successfully Completes FDA Inspection with Zero Observations
QTI FAQ — answered by Alphio AI
QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology. It operates in the Healthcare sector (ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS industry).
QT Imaging Holdings Inc appears to be a good buy right now due to its recent 103% revenue growth in Q2 2026, bringing total revenue to $7.4 million, and a current price of $3.09, which is below its historical SMA of $4.982. The company also received FDA approval for enhanced product capabilities, which could drive future sales. However, the main risk is the high debt-to-equity ratio of 680.85%, indicating potential financial instability.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。